JPRN-UMIN000001077已完成未知
Fluorouracil / Epirubicin / Cyclophosphamide (FEC) followed by Docetaxel plus Cyclophosphamide (TC) as adjuvant chemotherapy for node positive breast cancer - Fluorouracil / Epirubicin / Cyclophosphamide (FEC) followed by Docetaxel plus Cyclophosphamide (TC) as adjuvant chemotherapy for node positive breast cancer
Kinki Multidisciplinary Breast Oncology Group0 个研究点目标入组 35 人开始时间: 2008年3月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients who have received any prior therapy (hormonal therapy, chemotherapy, etc.) Pregnant or lactation women History of hypersensitivity reaction to drugs formulated with polysorbate Distant metastasis Patients judged by the investigator to be unfit to be enrolled into the study
研究者
相似试验
已完成
1 期
oral CEF(Cyclophosphamide, Epirubicin, UFT) adjuvant chemotherapy for breast cancer with intra-patient dose escalatioBreast cancerJPRN-C000000429Outpatient Oncology Unit Kyoto University Hospital26
进行中（未招募）
1 期
Phase ll Trial of Fludarabine & Cyclophosphamide followed by Thalidomide for Angioimmunoblastic Lymphoma - AITEUCTR2005-003931-40-GBniversity College London15
进行中（未招募）
1 期
5-Fluorouracil (5-FU), folinic acid and irinotecan (FOLFIRI) versus 5-FU and folinic acid as second-line chemotherapy in patients with biliary tract cancer (IRIBIL): a randomized open-label phase 2 studybiliary tract cancer not amedable for curative resection with progressive disease after first-line chematherapy with gemcitabine and cisplatinEUCTR2015-004028-69-DEGoethe-Universität Frankfurt, PD Fabian Finkelmeier56
招募中
2 期
5-Fluorouracil (5-FU), folinic acid and irinotecan (FOLFIRI) versus 5-FU and folinic acid as second-line chemotherapy in patients with biliary tract cancer (IRIBIL): a randomized open-label phase 2 studyC22C23Malignant neoplasm of liver and intrahepatic bile ductsMalignant neoplasm of gallbladderDRKS00012595Dekanat des Fachbereichs MedizinUniversitätsklinikum der Goethe-Universität Frankfurt27
已完成
2 期
Sequential chemotherapy with FEC(fluoraouracil, epirubicin and cyclophosphamide) and P+H(weekly Paclitaxel+Trastuzumab) as primary systemic therapy for operable breast cancer with HER2 positive disease-a phase 2 studyBreast CancerJPRN-C000000265Breast Cancer PST Study Group42